APLS - Apellis Pharmaceuticals, Inc.

QQQ $ 440.32 $ 0.07 (0.02 %)

DIA $ 388.70 $ 0.29 (0.07 %)

SPY $ 517.26 $ 0.57 (0.11 %)

TLT $ 90.79 $ 0.55 (0.61 %)

GLD $ 214.23 $ -0.99 (-0.46 %)

Previous Close

$ 43.9

Open

$ 45.67

Bid

$ 43.89 x 200

Ask

$ 43.98 x 100

Day's Range

$ 41.86 - $ 47.19

52 Week Range

$ 19.83 - $ 94.75

Volume

4,517,931

Average Volume

Market Cap

5.4B

Beta (5Y Monthly)

$ 0.91

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-07-2024	03-31-2024	10-Q
2	02-27-2024	12-31-2023	10-K
3	11-01-2023	09-30-2023	10-Q
4	07-31-2023	06-30-2023	10-Q
5	05-04-2023	03-31-2023	10-Q
6	02-21-2023	12-31-2022	10-K
7	11-07-2022	09-30-2022	10-Q
8	08-08-2022	06-30-2022	10-Q
9	05-04-2022	03-31-2022	10-Q
10	02-28-2022	12-31-2021	10-K
11	11-08-2021	09-30-2021	10-Q
12	08-09-2021	06-30-2021	10-Q
13	04-28-2021	03-31-2021	10-Q
14	02-25-2021	12-31-2020	10-K
15	11-02-2020	09-30-2020	10-Q
16	07-30-2020	06-30-2020	10-Q
17	04-29-2020	03-31-2020	10-Q
18	02-27-2020	12-31-2019	10-K
19	11-05-2019	09-30-2019	10-Q
20	07-31-2019	06-30-2019	10-Q
21	05-07-2019	03-31-2019	10-Q
22	02-26-2019	12-31-2018	10-K
23	11-13-2018	09-30-2018	10-Q
24	07-31-2018	06-30-2018	10-Q
25	04-30-2018	03-31-2018	10-Q
26	03-19-2018	12-31-2017	10-K
27	12-20-2017	09-30-2017	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Apellis Pharmaceuticals Q1 EPS $(0.54) Mis...
05/07/2024 11:10:34

Apellis Pharmaceuticals (NASDAQ:APLS) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimat...

Mizuho Maintains Neutral on Apellis Pharma...
04/29/2024 11:34:46

Mizuho analyst Graig Suvannavejh maintains Apellis Pharmaceuticals (NASDAQ:APLS) with a Neutral and lowers the price target ...

HC Wainwright & Co. Reiterates Buy on Apel...
04/26/2024 18:22:23

HC Wainwright & Co. analyst Douglas Tsao reiterates Apellis Pharmaceuticals (NASDAQ:APLS) with a Buy and maintains $92 p...

European Medicines Agency Has Reset The Re...
04/26/2024 11:19:34

Needham Reiterates Buy on Apellis Pharmace...
04/25/2024 17:15:07

Needham analyst Joseph Stringer reiterates Apellis Pharmaceuticals (NASDAQ:APLS) with a Buy and maintains $85 price target.

Wedbush Maintains Neutral on Apellis Pharm...
04/17/2024 16:26:41

Wedbush analyst Laura Chico maintains Apellis Pharmaceuticals (NASDAQ:APLS) with a Neutral and lowers the price target from ...

Expert Ratings For Apellis Pharmaceuticals
04/15/2024 14:00:43

HC Wainwright & Co. Reiterates Buy on Apel...
04/15/2024 11:07:14

HC Wainwright & Co. analyst Douglas Tsao reiterates Apellis Pharmaceuticals (NASDAQ:APLS) with a Buy and maintains $92 p...

if-you-invested-1000-in-this-stock-5-years-ago-you-would-have-3000-today

If You Invested $1000 In This Stock 5 Year...
04/10/2024 19:00:26

Needham Reiterates Buy on Apellis Pharmace...
04/09/2024 10:26:51

Needham analyst Joseph Stringer reiterates Apellis Pharmaceuticals (NASDAQ:APLS) with a Buy and maintains $85 price target.

1000-invested-in-this-stock-5-years-ago-would-be-worth-3000-today

$1000 Invested In This Stock 5 Years Ago W...
03/29/2024 21:00:22

Decoding 15 Analyst Evaluations For Apelli...
03/27/2024 18:01:31

Mizuho Maintains Neutral on Apellis Pharma...
03/27/2024 17:18:02

Mizuho analyst Graig Suvannavejh maintains Apellis Pharmaceuticals (NASDAQ:APLS) with a Neutral and maintains $60 price target.

peering-into-apellis-pharmaceuticalss-recent-short-interest

Peering Into Apellis Pharmaceuticals's Rec...
03/15/2024 13:15:13

JP Morgan Maintains Overweight on Apellis ...
03/06/2024 15:42:43

JP Morgan analyst Anupam Rama maintains Apellis Pharmaceuticals (NASDAQ:APLS) with a Overweight and raises the price target ...

UBS Maintains Buy on Apellis Pharmaceutica...
03/04/2024 14:57:34

UBS analyst Eliana Merle maintains Apellis Pharmaceuticals (NASDAQ:APLS) with a Buy and raises the price target from $87 to ...

Deep Dive Into Apellis Pharmaceuticals Sto...
02/28/2024 20:01:30

HC Wainwright & Co. Reiterates Buy on Apel...
02/28/2024 17:55:44

HC Wainwright & Co. analyst Douglas Tsao reiterates Apellis Pharmaceuticals (NASDAQ:APLS) with a Buy and maintains $92 p...

icu-medical-to-rally-around-28-here-are-10-top-analyst-forecasts-for-wednesday

ICU Medical To Rally Around 28%? Here Are ...
02/28/2024 13:07:42

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

Wedbush Maintains Neutral on Apellis Pharm...
02/28/2024 12:48:45

Wedbush analyst Laura Chico maintains Apellis Pharmaceuticals (NASDAQ:APLS) with a Neutral and raises the price target from ...